A comprehensive dose-response meta-analysis of 16 randomized controlled trials comprising over 1,000 patients found that oral ALA supplementation led to significant reductions in Fasting Plasma Glucose, HbA1c, and triglycerides
2003), or trifluoroacetic acid (TFA) (Mitamura et al
Additional factors warranting consideration include active malignancy, recent surgery or trauma, use of oestrogen-containing contraceptives or hormone replacement therapy, smoking, and certain inflammatory conditions such as inflammatory bowel disease
Shift to smaller, protein-forward mini-meals or snacks throughout the day
bringing a wonderful cooling experience, reducing acne and dark spots on the body
GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research